×
About 16,362 results

ALLMedicine™ Ascites Center

Research & Reviews  7,831 results

Pediatric Malignant Peritoneal Mesothelioma With Meningeal Metastasis.
https://doi.org/10.1097/MPH.0000000000002118
Journal of Pediatric Hematology/oncology; Aldrian D, Neu N et. al.

Feb 26th, 2021 - Malignant peritoneal mesothelioma (MPM) is an extremely rare entity with a poor prognosis. We report on a 16-year-old boy with ascites and abdominal distension. A computed tomography scan showed peritoneal thickening and a mass adjacent to the tra...

Clinical Predictors of Morbidity and Mortality in Hospitalized Pediatric Patients with ...
https://doi.org/10.1097/MPG.0000000000003104
Journal of Pediatric Gastroenterology and Nutrition; Ingviya T, Wasuwanich P et. al.

Feb 26th, 2021 - Ascites is a pathologic buildup of fluid in the peritoneal cavity. Knowledge is lacking in clinical outcome in pediatric patients with ascites. We aim to identify and assess clinical variables to associated with morbidity and mortality in pediatri...

Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases i...
https://doi.org/10.1002/cjp2.207
The Journal of Pathology. Clinical Research; Van't Erve I, Rovers KP et. al.

Feb 26th, 2021 - Tumor-derived cell-free DNA (cfDNA) is an emerging biomarker for guiding the personalized treatment of patients with metastatic colorectal cancer (CRC). While patients with CRC liver metastases (CRC-LM) have relatively high levels of plasma cfDNA,...

Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites.
https://doi.org/10.1177/0300060520986664
The Journal of International Medical Research; Kou F, Gong J et. al.

Feb 22nd, 2021 - This prospective, dose-escalation phase I study evaluated the safety and efficacy of intraperitoneal bevacizumab in managing refractory malignant ascites and explored the recommended dose of bevacizumab for further study. Patients with refractory ...

Transrectal endoscopic ultrasound in undiagnosed ascites: is it a peritoneal deposit?
https://doi.org/10.1055/a-1353-4637
Endoscopy Rana SS, Bush N et. al.

Feb 19th, 2021 - Transrectal endoscopic ultrasound in undiagnosed ascites: is it a peritoneal deposit?|2021|Rana SS,Bush N,Gupta R,|

see more →

Guidelines  9 results

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166105
Clinical and Molecular Hepatology;

Jul 11th, 2018 - KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.|2018| ,|therapeutic use,therapeutic use,diagnosis,etiology,metabolism,therapy,therapeutic use,complications,diagnosis,therapy,complications,diagnosis,analysis,

Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediat...
https://doi.org/10.1016/j.bbmt.2017.08.014
Biology of Blood and Marrow Transplantation : Journal of ... Mahadeo KM, McArthur J et. al.

Aug 21st, 2017 - Even though hepatic veno-occlusive disease (VOD) is a potentially fatal complication of hematopoietic cell transplantation (HCT), there is paucity of research on the management of associated multiorgan dysfunction. To help provide standardized car...

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised con...
https://doi.org/10.1136/gutjnl-2014-308874
Gut Angeli P, Gines P et. al.

Jan 29th, 2015 - Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.|2015|Angeli P,Gines P,Wong F,Bernardi M,Boyer TD,|complications,diagnosis,therapy,complications,

Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012
https://www.aasld.org/sites/default/files/guideline_documents/141020_Guideline_Ascites_4UFb_2015.pdf
Bruce A. Runyon

Dec 31st, 2011 - Cirrhosis is the eighth leading cause of death in the United States, if expanded liver diagnosis codes are used. 5 Ascites is the most common of the 3 major complications of cirrhosis, the other complications are hepatic encephalopathy and variceal.

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial p...
https://doi.org/10.1016/j.jhep.2010.05.004
Journal of Hepatology;

Jul 16th, 2010 - EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.|2010| ,|therapeutic use,diagnosis,etiology,therapy,diagnosis,etiology,therapy,therapeutic use,diagnosis,etiol...

see more →

Drugs  83 results see all →

Clinicaltrials.gov  8,151 results

Pediatric Malignant Peritoneal Mesothelioma With Meningeal Metastasis.
https://doi.org/10.1097/MPH.0000000000002118
Journal of Pediatric Hematology/oncology; Aldrian D, Neu N et. al.

Feb 26th, 2021 - Malignant peritoneal mesothelioma (MPM) is an extremely rare entity with a poor prognosis. We report on a 16-year-old boy with ascites and abdominal distension. A computed tomography scan showed peritoneal thickening and a mass adjacent to the tra...

Clinical Predictors of Morbidity and Mortality in Hospitalized Pediatric Patients with ...
https://doi.org/10.1097/MPG.0000000000003104
Journal of Pediatric Gastroenterology and Nutrition; Ingviya T, Wasuwanich P et. al.

Feb 26th, 2021 - Ascites is a pathologic buildup of fluid in the peritoneal cavity. Knowledge is lacking in clinical outcome in pediatric patients with ascites. We aim to identify and assess clinical variables to associated with morbidity and mortality in pediatri...

Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases i...
https://doi.org/10.1002/cjp2.207
The Journal of Pathology. Clinical Research; Van't Erve I, Rovers KP et. al.

Feb 26th, 2021 - Tumor-derived cell-free DNA (cfDNA) is an emerging biomarker for guiding the personalized treatment of patients with metastatic colorectal cancer (CRC). While patients with CRC liver metastases (CRC-LM) have relatively high levels of plasma cfDNA,...

Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites.
https://doi.org/10.1177/0300060520986664
The Journal of International Medical Research; Kou F, Gong J et. al.

Feb 22nd, 2021 - This prospective, dose-escalation phase I study evaluated the safety and efficacy of intraperitoneal bevacizumab in managing refractory malignant ascites and explored the recommended dose of bevacizumab for further study. Patients with refractory ...

Transrectal endoscopic ultrasound in undiagnosed ascites: is it a peritoneal deposit?
https://doi.org/10.1055/a-1353-4637
Endoscopy Rana SS, Bush N et. al.

Feb 19th, 2021 - Transrectal endoscopic ultrasound in undiagnosed ascites: is it a peritoneal deposit?|2021|Rana SS,Bush N,Gupta R,|

see more →

News  285 results

Hyponatremia Common in Patients With Indwelling Peritoneal Catheters
https://www.staging.medscape.com/viewarticle/940304

Nov 3rd, 2020 - NEW YORK (Reuters Health) - Hyponatremia is common in patients with indwelling peritoneal catheters for drainage of malignant ascites, according to a retrospective study. "We were surprised to find that over 80% of patients were hyponatremic after...

Hyponatremia Common in Patients With Indwelling Peritoneal Catheters
https://www.medscape.com/viewarticle/940304

Nov 3rd, 2020 - NEW YORK (Reuters Health) - Hyponatremia is common in patients with indwelling peritoneal catheters for drainage of malignant ascites, according to a retrospective study. "We were surprised to find that over 80% of patients were hyponatremic after...

Sarcopenia Does Not Worsen Survival After Shunting for Refractory Ascites
https://www.medscape.com/viewarticle/939918

Oct 28th, 2020 - NEW YORK (Reuters Health) - In patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites, sarcopenia is not associated with increased mortality, according to new research from the UK. "Until now...

Sarcopenia Does Not Worsen Survival After Shunting for Refractory Ascites
https://www.staging.medscape.com/viewarticle/939918

Oct 28th, 2020 - NEW YORK (Reuters Health) - In patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites, sarcopenia is not associated with increased mortality, according to new research from the UK. "Until now...

Lowering portal pressure boosts cirrhosis outcomes
https://www.mdedge.com/gihepnews/article/206752/hepatology/lowering-portal-pressure-boosts-cirrhosis-outcomes?channel=27970
Heidi Splete, MDedge News

Aug 20th, 2019 - Use of nonselective beta-blockers to reduce portal pressure in cirrhosis improved outcomes in adults with or without ascites, based on data from a meta-analysis of more than 1,000 patients. Wikimedia Commons/Cancer Research UK Two lobes of the liv.

see more →

Patient Education  3 results see all →